beta-lactams has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hannon Barroeta, P; McLoughlin, EC; Meegan, MJ; O'Boyle, NM; O'Brien, JE; Twamley, B; Zisterer, DM | 1 |
1 other study(ies) available for beta-lactams and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Synthesis by diastereomeric resolution, biochemical evaluation and molecular modelling of chiral 3-hydroxyl b-lactam microtubule-targeting agents for the treatment of triple negative breast and chemoresistant colorectal cancers.
Topics: beta-Lactams; Colorectal Neoplasms; Humans; Lactams; Microtubules; Myeloid Cell Leukemia Sequence 1 Protein; Structure-Activity Relationship; Triple Negative Breast Neoplasms; Tubulin | 2023 |